002020 京新药业
已收盘 10-30 15:00:00
资讯
新帖
简况
京新药业（002020）2026年三季报简析：净利润同比下降8.43%
证券之星 · 10-31 07:42
京新药业（002020）2026年三季报简析：净利润同比下降8.43%
股市必读：京新药业三季报 - 第三季度单季净利润同比下降6.52%
证券之星 · 10-30 06:03
股市必读：京新药业三季报 - 第三季度单季净利润同比下降6.52%
京新药业(002020)9月30日股东户数4.13万户，较上期增加25.34%
证券之星 · 10-29
京新药业(002020)9月30日股东户数4.13万户，较上期增加25.34%
图解京新药业三季报：第三季度单季净利润同比下降6.52%
证券之星 · 10-29
图解京新药业三季报：第三季度单季净利润同比下降6.52%
京新药业：JX2201降脂药目前处在临床II期
证券之星 · 10-28
京新药业：JX2201降脂药目前处在临床II期
京新药业：公司H股上市事项在正常推进中
证券之星 · 10-28
京新药业：公司H股上市事项在正常推进中
股市必读：京新药业（002020）10月21日董秘有最新回复
证券之星 · 10-22
股市必读：京新药业（002020）10月21日董秘有最新回复
股市必读：京新药业（002020）10月16日董秘有最新回复
证券之星 · 10-19
股市必读：京新药业（002020）10月16日董秘有最新回复
京新药业（002020）10月13日主力资金净卖出189.81万元
证券之星 · 10-14
京新药业（002020）10月13日主力资金净卖出189.81万元
研报掘金丨东吴证券：京新药业创新转型有望持续兑现，维持“买入”评级
格隆汇 · 10-13
研报掘金丨东吴证券：京新药业创新转型有望持续兑现，维持“买入”评级
京新药业：回购股份比例达1.02% 累计耗资1.10亿元
同花顺 · 10-12
京新药业：回购股份比例达1.02% 累计耗资1.10亿元
股市必读：京新药业新发布《关于股份回购进展公告》
证券之星 · 10-09
股市必读：京新药业新发布《关于股份回购进展公告》
京新药业：截至9月30日公司回购股份708.93万股
同花顺 · 10-07
京新药业：截至9月30日公司回购股份708.93万股
京新药业（002020）9月28日主力资金净卖出1210.07万元
证券之星 · 09-29
京新药业（002020）9月28日主力资金净卖出1210.07万元
京新药业二度递表港交所：高溢价关联收购后遗症显现 实控人5年拿走7亿后又向市场要钱
新浪证券 · 09-24
京新药业二度递表港交所：高溢价关联收购后遗症显现 实控人5年拿走7亿后又向市场要钱
京新药业：公司盐酸卡立派嗪在国内属于首家上市，属于仿制药
证券之星 · 09-24
京新药业：公司盐酸卡立派嗪在国内属于首家上市，属于仿制药
京新药业：深圳巨烽经营稳定，业绩稳定增长
证券之星 · 09-24
京新药业：深圳巨烽经营稳定，业绩稳定增长
京新药业再度向港交所递交上市申请 中信证券独家保荐
观点地产网 · 09-21
京新药业再度向港交所递交上市申请 中信证券独家保荐
2026年上半年业绩双降，京新药业二度递表港交所
蓝鲸财经 · 09-21
2026年上半年业绩双降，京新药业二度递表港交所
京新药业（002020）披露H股发行上市申请资料更新进展，9月21日股价上涨3.07%
证券之星 · 09-21
京新药业（002020）披露H股发行上市申请资料更新进展，9月21日股价上涨3.07%
加载更多
公司概况
公司名称：
浙江京新药业股份有限公司
所属行业：
医药制造业
上市日期：
2004-07-15
主营业务：
浙江京新药业股份有限公司的主营业务是化学制剂、传统中药、生物制剂、化学原料药、医疗器械的研发、生产及销售。公司的主要产品是化学制剂、中成药、生物制剂、化学原料药、医疗器械。公司为国家重点高新技术企业。
发行价格：
10.05
{"stockData":{"symbol":"002020","market":"SZ","secType":"STK","nameCN":"京新药业","latestPrice":11.25,"timestamp":1793343813000,"preClose":11.06,"halted":0,"volume":14757967,"delay":0,"changeRate":0.0172,"floatShares":724000000,"shares":861000000,"eps":0.824,"marketStatus":"已收盘","change":0.19,"latestTime":"10-30 15:00:00","open":10.99,"high":11.4,"low":10.91,"amount":165000000,"amplitude":0.0443,"askPrice":11.25,"askSize":337,"bidPrice":11.24,"bidSize":131,"shortable":0,"etf":0,"ttmEps":0.824,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":5,"adr":0,"adjPreClose":11.06,"symbolType":"stock","openAndCloseTimeList":[[1793323800000,1793331000000],[1793336400000,1793343600000]],"highLimit":12.17,"lowLimit":9.95,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":861029140,"isCdr":false,"pbRate":1.59,"roa":"--","peRate":13.652913,"roe":"8.78%","epsLYR":0.92,"committee":-0.12541,"marketValue":9687000000,"turnoverRate":0.0204,"status":0,"floatMarketCap":8145000000},"requestUrl":"/m/hq/s/002020","defaultTab":"news","newsList":[{"id":"2679522547","title":"京新药业（002020）2026年三季报简析：净利润同比下降8.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679522547","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679522547?lang=zh_cn&edition=full","pubTime":"2026-10-31 07:42","pubTimestamp":1793403766,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期京新药业发布2026年三季报。根据财报显示，京新药业净利润同比下降8.43%。截至本报告期末，公司营业总收入30.36亿元，同比下降0.41%，归母净利润5.27亿元，同比下降8.43%。按单季度数据看，第三季度营业总收入10.49亿元，同比上升1.63%，第三季度归母净利润1.75亿元，同比下降6.52%。2026 年上半年，地达西尼延续增长态势，销售额达 1.53 亿元。本文数据来源于京新药业2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100016739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679377292","title":"股市必读：京新药业三季报 - 第三季度单季净利润同比下降6.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679377292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679377292?lang=zh_cn&edition=full","pubTime":"2026-10-30 06:03","pubTimestamp":1793311433,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘，京新药业报收于11.06元，下跌0.09%，换手率1.12%，成交量8.1万手，成交额8968.37万元。股本股东变化：截至2026年9月30日股东户数为4.13万户，较6月30日增长25.34%。业绩披露要点：2026年前三季度归母净利润5.27亿元，同比下降8.43%。2026年第三季度单季度主营收入10.49亿元，同比上升1.63%；单季度归母净利润1.75亿元，同比下降6.52%；单季度扣非净利润1.61亿元，同比下降9.21%；负债率25.52%，投资收益1608.19万元，财务费用-103.86万元，毛利率50.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000009862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679740385","title":"京新药业(002020)9月30日股东户数4.13万户，较上期增加25.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679740385","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679740385?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:03","pubTimestamp":1793271803,"startTime":"0","endTime":"0","summary":"证券之星消息，近日京新药业披露，截至2026年9月30日公司股东户数为4.13万户，较6月30日增加8343.0户，增幅为25.34%。在化学制药行业个股中，京新药业股东户数高于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.95万户。从股价来看，2026年6月30日至2026年9月30日，京新药业区间跌幅为5.28%，在此期间股东户数增加8343.0户，增幅为25.34%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900045510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679415666","title":"图解京新药业三季报：第三季度单季净利润同比下降6.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679415666","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679415666?lang=zh_cn&edition=full","pubTime":"2026-10-29 03:23","pubTimestamp":1793215383,"startTime":"0","endTime":"0","summary":"证券之星消息，京新药业2026年三季报显示，前三季度公司主营收入30.36亿元，同比下降0.41%；归母净利润5.27亿元，同比下降8.43%；扣非净利润5.03亿元，同比下降6.49%；其中2026年第三季度，公司单季度主营收入10.49亿元，同比上升1.63%；单季度归母净利润1.75亿元，同比下降6.52%；单季度扣非净利润1.61亿元，同比下降9.21%；负债率25.52%，投资收益1608.19万元，财务费用-103.86万元，毛利率50.81%。财报数据概要请见下图:本文数据来源于京新药业2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900003779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678434992","title":"京新药业：JX2201降脂药目前处在临床II期","url":"https://stock-news.laohu8.com/highlight/detail?id=2678434992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678434992?lang=zh_cn&edition=full","pubTime":"2026-10-28 13:00","pubTimestamp":1793163619,"startTime":"0","endTime":"0","summary":"证券之星消息，京新药业(002020)10月28日在投资者关系平台上答复投资者关心的问题。投资者提问：请问降脂创新药还在继续么？公司还有什么亮点？京新药业回复：您好，公司的JX2201降脂药目前处在临床II期。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800026197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678434994","title":"京新药业：公司H股上市事项在正常推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2678434994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678434994?lang=zh_cn&edition=full","pubTime":"2026-10-28 13:00","pubTimestamp":1793163617,"startTime":"0","endTime":"0","summary":"证券之星消息，京新药业(002020)10月28日在投资者关系平台上答复投资者关心的问题。投资者提问：好多国内公司已经开始撤回在港交所上市的申请，请问公司是否也在考虑撤回申请了？京新药业回复：您好！公司H股上市事项在正常推进中。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800026195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677098906","title":"股市必读：京新药业（002020）10月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2677098906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677098906?lang=zh_cn&edition=full","pubTime":"2026-10-22 02:07","pubTimestamp":1792606030,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘，京新药业报收于11.46元，下跌1.12%，换手率1.14%，成交量8.26万手，成交额9558.32万元。董秘最新回复投资者： 问吕董，公司回复说公司准创新药盐酸卡立哌嗪销售依托公司一类创新药地达西尼网络，那么问公司盐酸卡立哌嗪上市也一个多月了，现在进入多少家医院了？谢谢您对公司的关注，公司会积极推进盐酸卡立哌嗪的销售工作。当日关注点交易信息汇总：10月21日主力资金净流出459.36万元，占总成交额4.81%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200001461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676573405","title":"股市必读：京新药业（002020）10月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2676573405","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676573405?lang=zh_cn&edition=full","pubTime":"2026-10-19 03:55","pubTimestamp":1792353310,"startTime":"0","endTime":"0","summary":"截至2026年10月16日收盘，京新药业报收于11.28元，下跌0.88%，换手率2.1%，成交量15.2万手，成交额1.75亿元。董秘最新回复投资者： 你好现在还有多少股东董秘： 您好！对于非定期报告的股东人数，股东可向公司董秘办提供股东证明，经核实后予以提供。当日关注点交易信息汇总：10月16日主力资金净流出97.92万元，占总成交额0.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900001202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675739964","title":"京新药业（002020）10月13日主力资金净卖出189.81万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675739964","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675739964?lang=zh_cn&edition=full","pubTime":"2026-10-14 09:18","pubTimestamp":1791940714,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月13日收盘，京新药业报收于11.49元，下跌1.79%，换手率2.02%，成交量14.6万手，成交额1.67亿元。近5日资金流向一览见下表：京新药业融资融券信息显示，融资方面，当日融资买入1538.24万元，融资偿还1454.07万元，融资净买入84.17万元，连续3日净买入累计754.17万元。融券方面，融券卖出200.0股，融券偿还4200.0股，融券余量27.78万股，融券余额319.19万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400008494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675338487","title":"研报掘金丨东吴证券：京新药业创新转型有望持续兑现，维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2675338487","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675338487?lang=zh_cn&edition=full","pubTime":"2026-10-13 13:38","pubTimestamp":1791869915,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0276","BK0012","BK0183","002020","BK0239","BK0028","601555","BK0188","BK0009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674876349","title":"京新药业：回购股份比例达1.02% 累计耗资1.10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674876349","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674876349?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:43","pubTimestamp":1791798180,"startTime":"0","endTime":"0","summary":"10月12日，京新药业(002020.SZ)公告称，公司拟使用自有资金以集中竞价方式回购股份用于注销并减少注册资本，回购总金额不低于1亿元、不超过2亿元，回购价格不超过19元/股，回购实施期限自20 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261012/c680599613.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261012/c680599613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674004866","title":"股市必读：京新药业新发布《关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674004866","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674004866?lang=zh_cn&edition=full","pubTime":"2026-10-09 01:37","pubTimestamp":1791481028,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，京新药业报收于11.7元，下跌1.1%，换手率2.99%，成交量21.64万手，成交额2.57亿元。公司公告汇总：截至2026年9月30日，京新药业已回购股份708.93万股，占总股本0.82%，成交总金额8995.6921万元，回购进展符合方案要求。公司公告汇总关于股份回购进展公告浙江京新药业股份有限公司于2026年7月2日召开第九届董事会第五次会议，2026年7月20日召开2026年第二次临时股东会，审议通过《关于回购公司股份用于注销并减少注册资本的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900001814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002020","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018774","title":"京新药业：截至9月30日公司回购股份708.93万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018774","media":"同花顺","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673018774?lang=zh_cn&edition=full","pubTime":"2026-10-07 20:32","pubTimestamp":1791376320,"startTime":"0","endTime":"0","summary":" 证券日报网讯 10月7日，京新药业发布公告称，截至2026年9月30日，公司通过股份回购专用证券账户以集中竞价方式回购公司股份708.93万股，占公司总股本的0.82% ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261007/c680448637.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261007/c680448637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["002020","BK0239","SURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671269050","title":"京新药业（002020）9月28日主力资金净卖出1210.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671269050","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671269050?lang=zh_cn&edition=full","pubTime":"2026-09-29 09:08","pubTimestamp":1790644129,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，京新药业报收于11.35元，上涨0.89%，换手率1.68%，成交量12.15万手，成交额1.37亿元。近5日资金流向一览见下表：京新药业融资融券信息显示，融资方面，当日融资买入1098.91万元，融资偿还1587.89万元，融资净偿还488.99万元。京新药业主营业务：化学制剂、传统中药、生物制剂、化学原料药、医疗器械的研发、生产及销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900008282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002020","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669446362","title":"京新药业二度递表港交所：高溢价关联收购后遗症显现 实控人5年拿走7亿后又向市场要钱","url":"https://stock-news.laohu8.com/highlight/detail?id=2669446362","media":"新浪证券","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669446362?lang=zh_cn&edition=full","pubTime":"2026-09-24 16:38","pubTimestamp":1790239080,"startTime":"0","endTime":"0","summary":"高溢价关联收购后遗症显现 账上现金充裕仍赴港募资除了业务方面面临的挑战之外，京新药业在公司治理层面同样存在隐忧。2021年底，京新药业以2.05亿元收购实控人吕钢旗下的广东沙溪制药100%股权，全部对价以上市公司自有资金支付。截至2026年上半年，京新药业货币资金、交易性金融资产及各期限定期存单构成的类现金资产规模超过23亿元，同期有息负债仅约2亿元。仅现金分红一项，实控人体系每年即可稳定获得超1亿元的现金回报。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-09-24/doc-inisxnuz4956180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","002020","HEXmain","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669566456","title":"京新药业：公司盐酸卡立派嗪在国内属于首家上市，属于仿制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2669566456","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669566456?lang=zh_cn&edition=full","pubTime":"2026-09-24 11:36","pubTimestamp":1790221001,"startTime":"0","endTime":"0","summary":"证券之星消息，京新药业(002020)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，京新药业盐酸卡利哌嗪同是购买匈牙利配方专利，艾伯雄为啥叫原研药，京新药业盐酸卡利哌嗪就叫仿制药？29年一月一日专利到期，两年我们也该叫原研药，为啥我们自降身份呢？京新药业回复：您好！公司盐酸卡立派嗪在国内属于首家上市，属于仿制药，符合国内的相关政策，公司会积极推进盐酸卡立哌嗪的销售工作，尽快给公司贡献收入。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400016902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669565574","title":"京新药业：深圳巨烽经营稳定，业绩稳定增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2669565574","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669565574?lang=zh_cn&edition=full","pubTime":"2026-09-24 11:36","pubTimestamp":1790221001,"startTime":"0","endTime":"0","summary":"证券之星消息，京新药业(002020)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：问吕董，公司子公司深圳巨烽做为医疗器械显示器方面的龙头对比市场上五州医疗、采纳服你等等，无论营收还是净利润都远远比不上深圳巨烽而它们的市值确高达近百亿，几乎赶上京新药业母公市值，如此为何母公司不引入战投，分拆上市。做大做强。京新药业回复：您好！谢谢您的建议，目前深圳巨烽经营稳定，业绩稳定增长，公司会综合考虑其未来发展的方向。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400016906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669610171","title":"京新药业再度向港交所递交上市申请 中信证券独家保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2669610171","media":"观点地产网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669610171?lang=zh_cn&edition=full","pubTime":"2026-09-21 22:32","pubTimestamp":1790001120,"startTime":"0","endTime":"0","summary":"观点网讯：9月18日，京新药业向港交所主板递交上市申请，中信证券为其独家保荐人。京新药业是一家A股上市逾20年的制药企业，此次为其二度冲刺港股。此前其于2026年2月首次递表，后因6个月有效期届满而失效。免责声明：本文内容与数据由观点根据公开信息整理，不构成投资建议，使用前请核实。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/estate/integration/2026-09-21/doc-inisrhft7489895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HEXmain","LU1146622755.USD","BK0276","600030","LU0405327494.USD","LU2289578879.USD","LU1064130708.USD","IPOS","002020","LU1255011170.USD","LU1997244956.HKD","BK1521","LU2495084118.USD","BK1147","LU0405327148.USD","LU1720050803.USD","LU1997245094.SGD","LU1997245177.USD","BK1516","LU1328615791.USD","LU2580892862.HKD","LU1820825898.SGD","06030","BK0012","LU2580892789.USD","BK0183","LU1064131003.USD","LU1794554557.SGD","LU1580142542.USD","LU1655091616.SGD","LU2148510915.USD","BK0239","BK1564","LU1781817850.SGD","BK0188","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669157831","title":"2026年上半年业绩双降，京新药业二度递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2669157831","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669157831?lang=zh_cn&edition=full","pubTime":"2026-09-21 18:11","pubTimestamp":1789985471,"startTime":"0","endTime":"0","summary":"从目前的业绩表现来看，2023年至2025年其营收几乎原地踏步，毛利率出现下滑；2026年上半年，该公司营收、净利润出现双降。税务处罚阴影除了业绩表现出现停滞甚至下滑，在递表港交所的过程中，京新药业的一项合规瑕疵受到市场关注。这一金额主要包括2021年至2023年的补充企业所得税约1080万元、过往年度最终结算调整约160万元，以及前述少缴的企业所得税约100万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789985380753917426","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0239","IPOS","002020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669646154","title":"京新药业（002020）披露H股发行上市申请资料更新进展，9月21日股价上涨3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669646154","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669646154?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:36","pubTimestamp":1789983376,"startTime":"0","endTime":"0","summary":"截至2026年9月21日收盘，京新药业报收于11.75元，较前一交易日上涨3.07%，最新总市值为101.17亿元。京新药业当日发布公告称，公司已于2026年2月11日向香港联交所递交H股发行上市申请，并于2026年9月18日更新递交申请材料，同日在香港联交所网站刊发更新后的申请资料。公司本次发行上市尚需获得中国证监会、香港证监会及香港联交所等监管机构的批准，存在不确定性。公司不会在境内媒体刊登该资料，但提供香港联交所网站链接供查阅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100022379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002020"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793560362206,"stockEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":-0.049},{"period":"3month","weight":-0.1752},{"period":"6month","weight":-0.2182},{"period":"1year","weight":-0.3434},{"period":"ytd","weight":-0.3911}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江京新药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41264人(较上一季度减少77.01%)","perCapita":"0股","listingDate":"2004-07-15","address":"浙江省绍兴市新昌县羽林街道新昌大道东路800号","registeredCapital":"86102万元","survey":" 浙江京新药业股份有限公司的主营业务是化学制剂、传统中药、生物制剂、化学原料药、医疗器械的研发、生产及销售。公司的主要产品是化学制剂、中成药、生物制剂、化学原料药、医疗器械。公司为国家重点高新技术企业。","listedPrice":10.05},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"京新药业(002020)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供京新药业(002020)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"京新药业,002020,京新药业股票,京新药业股票老虎,京新药业股票老虎国际,京新药业行情,京新药业股票行情,京新药业股价,京新药业股市,京新药业股票价格,京新药业股票交易,京新药业股票购买,京新药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"京新药业(002020)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供京新药业(002020)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}